Stocks in news: Adani Enterprises, Tata Motors PV, Tata Steel, Jio Financial, ITC HotelsMarkets extended their rebound for a second consecutive session on Thursday, buoyed by supportive global cues and selective buying in heavy...
15 May, 2026, 06.35 AM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIn the stock market, everything has to be seen in context. The most noticeable thing these past few days is that there is not much Gulf-rel...
13 May, 2026, 11.39 PM IST
Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
10 May, 2026, 12.18 AM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
29 Apr, 2026, 11.57 PM IST
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
29 Apr, 2026, 02.22 PM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
22 Apr, 2026, 10.08 PM IST
Stocks in news: Wipro, HUL, Angel One, Alembic Pharma, HDFC LifeMarkets ended flat on Thursday after a volatile session, with analysts maintaining a positive outlook and recommending a buy-on-dips strate...
17 Apr, 2026, 06.18 AM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
15 Apr, 2026, 09.16 PM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe markets should be in a happy frame of mind till the time the current ceasefire in the Gulf region holds. Not many may like us using the...
08 Apr, 2026, 09.23 PM IST
Midcap stock zooms 9% on receiving USFDA approval for glaucoma drugBrimonidine Tartrate Ophthalmic Solution is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressu...
31 Mar, 2023, 01.38 PM IST
Hold Alembic Pharmaceuticals, target price Rs 660: JM FinancialJM Financial has reduced its earnings by 10% in FY24/25 adjusting for higher costs, depreciation and lower other income.
02 Feb, 2023, 01.22 PM IST
Buy Alembic Pharmaceuticals, target price Rs 653: ICICI SecuritiesAlembic Pharmaceuticals, incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 10695.00 Crore) operating in Pharma...
02 Feb, 2023, 10.10 AM IST
Hold Alembic Pharmaceuticals, target price Rs 730: JM FinancialAlembic Pharmaceuticals, incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 11514.67 Crore) operating in Pharma...
23 Dec, 2022, 01.15 PM IST
Alembic Pharma jumps over 6% on getting approval from USFDA for Mesalamine extended-release capsules“The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Apriso Extended-Release Capsules, 0.375 g, of ...
02 Nov, 2022, 01.45 PM IST
Reduce Alembic Pharmaceuticals, target price Rs 641: ICICI SecuritiesAlembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 13347.62 Crore) operating in P...
05 Aug, 2022, 11.25 AM IST
Neutral on Alembic Pharmaceuticals, target price Rs 750: Motilal Oswal Financial ServicesAlembic Pharma delivered a better than expected operational performance, led by better-than-industry growth in the Domestic Formulations (D...
04 May, 2022, 11.07 AM IST
Alembic Pharma tanks 10% after flop show in Q1Shares of Alembic Pharmaceuticals declined 10 per cent to Rs 822.60, its new 52-week low, on Tuesday.
27 Jul, 2021, 11.29 AM IST